Emerging in the field of obesity management, retatrutide presents a unique strategy. Beyond many existing medications, retatrutide operates as a dual agonist, at once engaging both GLP-like peptide-1 (GLP-1) and https://arraneosv177133.arwebo.com/61006296/the-novel-retatrutide-this-glp-gip-binding-site-agonist